Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - CEREBAIN BIOTECH CORP.Financial_Report.xls
EX-31.1 - CEREBAIN BIOTECH CORP.ex-31_1.htm
EX-10.8 - CEREBAIN BIOTECH CORP.ex_10-8.htm
10-Q - CEREBAIN BIOTECH CORP.dis-den_10q.htm
EXHIBIT 32.1


CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Discount Dental Materials, Inc. (the "Company") on Form 10-Q for the period ended September 30, 2012 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Gerald DeCiccio, President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: November 14, 2012
 
  Company Name  
       
 
By:
/s/ GERALD DECICCIO  
    Gerald DeCiccio  
    President (Principal Executive Officer and Principal Financial and Accounting Officer)  
 

A signed original of this written statement required by Section 906 has been provided to Discount Dental Materials, Inc. and will be retained by Discount Dental Materials, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.